Efficacy and Safety of Atomoxetine in Children With Recent Diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD)
Clinical trial NCT00191945 · COMPLETED
Trial details
- NCT number
- NCT00191945
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2008-02-01
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.